Global BioImaging 3rd Open Call of i4A Access Grant Program 2026
Deadline: Feb 28, 2026
other
partially funded
Global
Opportunity Overview
π About the Program
The i4A Access Grant is designed to support researchers in visualizing biological samples, developing imaging assays, and exploring scientific questions using state-of-the-art imaging technologies. This program promotes:
- Knowledge exchange
- Professional growth
- Institutional capacity building in low- and middle-income countries
π Benefits
- Grants cover expenses for facility access, travel, and associated costs.
- Total funding may not exceed EUR 10,000 per applicant.
- Funding supports one visit per applicant to ensure focused learning and collaboration.
β Eligibility Criteria
Applicants must meet the following requirements:
- Be researchers or imaging facility staff/management affiliated with universities or research institutes.
- Be based in eligible low- and middle-income countries.
- Individual applicants are considered the primary grant recipients.
- Visits cannot be hosted at the applicant's own institution to encourage broader collaboration.
π Application Date and Process
Steps to Apply:
- Identify a host imaging facility outside your own institution.
- Develop a clear plan for the visit, outlining specific imaging techniques, assays, or research goals.
- Submit an application detailing:
- Your professional background
- Proposed activities
- Expected outcomes
- Include a justification for the visitβs duration and budget, if requesting longer than four weeks.
- Ensure alignment with the grantβs goal of building capacity in LMIC research environments.
β° Application Deadline
28 February, 2026
π Application Portal
View details of the program on the Global BioImaging website.
Apply directly via the registration link.
Benefits
- Grants cover expenses for facility access, travel, and associated costs.
- Total funding may not exceed EUR 10,000 per applicant.
- Funding supports one visit per applicant to ensure concentrated learning and collaboration.







